ODDConsumer Defensive · Household & Personal ProductsThe 11 Wall Street analysts covering ODDITY Tech Ltd. hold a median 12-month price target of $18 — -20.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 15 of 100 as at 22 Oct 2026 — in the weakest quartile.
Consensus tells you what everyone already believes. The model scores ODDITY Tech Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (93): Analysts have, on balance, been raising their forecasts.
Growth (8): Sales and profits are flat, shrinking, or growing more slowly than they were.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on ODD, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits −20.5% from it.
Of the 20 most recent actions, 6 moved their price target up and 3 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 15 Oct 2026 | Morgan Stanley | Maintains | Equal-Weight | $17 → $19 |
| 21 Sept 2026 | JP Morgan | Reinstates | Neutral | $18 |
| 10 Sept 2026 | Evercore ISI Group | Maintains | In-Line | — |
| 10 Sept 2026 | Evercore ISI Group | Maintains | In-Line | $15 → $21 |
| 10 Sept 2026 | Morgan Stanley | Maintains | Equal-Weight | $10 → $17 |
| 10 Sept 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 10 Sept 2026 | Truist Securities | Maintains | Hold | — |
| 10 Sept 2026 | Truist Securities | Maintains | Hold | $16 → $18 |
| 9 Sept 2026 | Jefferies | Maintains | Hold | $16 → $18 |
| 9 Sept 2026 | Jefferies | Maintains | Hold | — |
| 8 Sept 2026 | Needham | Reiterates | Hold | — |
| 8 Sept 2026 | Needham | Reiterates | Hold | — |
| 1 Sept 2026 | Truist Securities | Maintains | Hold | — |
| 1 Sept 2026 | Truist Securities | Maintains | Hold | $12 → $16 |
| 4 June 2026 | Evercore ISI Group | Maintains | In-Line | — |
| 4 June 2026 | Evercore ISI Group | Maintains | In-Line | $23 → $15 |
| 3 June 2026 | Barclays | Maintains | Underweight | — |
| 3 June 2026 | Barclays | Maintains | Underweight | $13 → $8.00 |
| 3 June 2026 | Goldman Sachs | Downgrade | Sell | — |
| 3 June 2026 | Goldman Sachs | Downgrade | Sell | $16 → $8.00 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
ODD appears in the Radar on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 23 Oct 2026, ODDITY Tech Ltd. returned −52.0% against +14.3% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 7% of US stocks
Cheaper than 59% of US stocks
Cheaper than 22% of US stocks
Cheaper than 1% of US stocks
Higher than 10% of US stocks
Higher than 6% of US stocks
Higher than 82% of US stocks
Higher than 31% of US stocks
Higher than 53% of US stocks
Higher than 54% of US stocks
Higher than 42% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
ODDITY Tech Ltd. has a market value of $1.0B and an enterprise value of $1.5B.
Revenue in the twelve months to 30 June 2026: $679.1M. The latest quarter shrank 25.1% year on year.
Net income over the same four quarters: $15.2M, a 2.2% net margin.
Diluted earnings per share, trailing twelve months: $0.24.
Free cash flow in the twelve months to 30 June 2026: −$35.5M.
ODDITY Tech Ltd. spent $162.8M on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 103.7×; forward P/E: 20.1× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
ODDITY Tech Ltd. employs 658 people — $1.0M of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own ODDITY Tech Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Oddity Tech (ODD) was upgraded to Zacks Rank #1 (Strong Buy), reflecting growing optimism about its earnings prospects.
Why it matters — ODD watchers may note the upgrade as a sign of increased optimism about the company’s earnings prospects.
Zacks Investment Research added ODD, along with KMX, ACIC, ONC and WES, to its Zacks Rank #1 (Strong Buy) List on October 15, 2026.
Why it matters — ODD watchers may note the stock’s inclusion in Zacks’ Strong Buy list.
Nanjing Leads Biolabs announced that its proprietary PD-L1/4-1BB bispecific antibody, opamtistomig (LBL-024), has been granted Orphan Drug Designation by Japan's MHLW for the treatment of extrapulmonary neuroendocrine carcinoma (EP-NEC). This marks the third such designation for the drug, following earlier ones from the U.S. FDA and the European Commission, expanding its global regulatory recognition into an Asian market.
Why it matters — A watcher of ODD would care because this third orphan drug designation for opamtistomig extends its regulatory recognition into a strategically important Asian market, broadening the drug's global footprint across Japan, the U.S., and Europe.
Zacks reports that Oddity Tech (ODD) shares have begun gaining and may continue rising in the near term, based on solid upward earnings estimate revisions for the company.
Why it matters — A watcher of ODD would care because improving earnings estimate revisions signal growing analyst confidence in the company's near-term performance.
The article discusses Oddity Tech's turnaround potential, citing improving acquisition costs, growing revenue from SpoiledChild, and longer-term opportunities from METHODIQ and Labs. It also highlights the company's convertible bonds trading at a discount with a 0% coupon, which it calls cheap debt offering flexibility and a value lever.
Why it matters — ODD watchers would care because the piece highlights multiple growth avenues and a discounted convertible debt position that could provide financial flexibility beyond IL MAKIAGE's recovery.
The 11 Wall Street analysts covering ODDITY Tech Ltd. have a median 12-month price target of $18, with estimates ranging from $9 to $22. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 11 analysts covering ODDITY Tech Ltd., 0 rate it a Buy, 8 a Hold and 3 a Sell. Ticker Nerd's systematic factor model ranks ODDITY Tech Ltd. 15 out of 100 across roughly 4,600 US stocks as at 22 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 22 Oct 2026, ODDITY Tech Ltd. ranks 15 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (93 of 100).
No one can know that. What the data says: the median 12-month target from 11 analysts implies -20.5% from the last close, and Ticker Nerd's factor model ranks ODDITY Tech Ltd. 15 out of 100 as at 22 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering ODDITY Tech Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ODD are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $9 to $22 over the next 12 months.
ODDITY Tech Ltd. returned -52.0% over the 12 months to 23 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Oddity Tech Ltd. Class A Ordinary Shares represent ownership in Oddity Tech Ltd., a consumer technology company focused on beauty and wellness.
The most recent item we track (Zacks Investment Research, 15 Oct 2026): "Oddity Tech (ODD) Upgraded to Strong Buy: Here's What You Should Know". Oddity Tech (ODD) was upgraded to Zacks Rank #1 (Strong Buy), reflecting growing optimism about its earnings prospects.
Oddity Tech Ltd. Class A Ordinary Shares represent ownership in Oddity Tech Ltd., a consumer technology company focused on beauty and wellness. The company develops and operates digital-first brands through an online platform that uses data science, machine learning, and computer vision to identify consumer needs and create product offerings. Its current business centers on cosmetics, personal care, and wellness products distributed directly to consumers, with brands that serve a broad international customer base. Oddity Tech also supports its consumer business with technology-driven product development and digital commerce capabilities, making the company notable for blending software-like tools with consumer packaged goods. Oddity Tech Ltd. is headquartered in Tel Aviv-Jaffa, Israel, and its Class A Ordinary Shares are the public equity class used to represent investor ownership in the business.
CEO Mr. Oran Holtzman · 658 employees · Israel · https://oddity.com
